OBJECTIVES: Low serum IGF-I is an independent risk factor for diabetes and cardiovascular disease. These noncommunicable diseases are extremely common in urban black South Africans, but their IGF-I concentration is unknown. We aimed to compare serum IGF-I concentrations of African and Caucasian people, investigate their age-related IGF-I decline, and determine whether IGF-I could account, at least in part, for the high prevalence of noncommunicable diseases in black Africans. RESEARCH DESIGN AND METHODS: This cross-sectional study involved 211 African and 316 Caucasian men and women (aged 20-70 yr). Fasting glucose, insulin, lipids, albumin, creatinine, liver enzymes, cotinine, high-sensitivity C-reactive protein, reactive oxygen species, IGF-I, blood pressure (BP), and pulse wave velocity were determined. RESULTS: IGF-I was lower in Africans (P < 0.001) and in both ethnicities declined significantly by age quartiles (P < 0.001). In African men and women, IGF-I declined significantly from age quartile 1 to 2 (r = -0.65, P < 0.001), not seen in young Caucasian men and women (r = -0.08, P = 0.45; r = -0.10, P = 0.34). This was confirmed after adjustment for BP, insulin resistance, high-sensitivity C-reactive protein, cotinine, gamma-glutamyl transferase, and reactive oxygen species. Only young Africans showed significant negative correlations of IGF-I with BP, pulse wave velocity, and high-density lipoprotein cholesterol. CONCLUSIONS: Africans presented lower IGF-I levels than Caucasians due to an accelerated decline in serum IGF-I concentration prior to 40 yr of age. Strong associations of low serum IGF-I with blood pressure and arterial stiffness in young Africans suggest that the loss of cardiometabolic protection by IGF-I could predispose them to earlier disease onset.
OBJECTIVES: Low serum IGF-I is an independent risk factor for diabetes and cardiovascular disease. These noncommunicable diseases are extremely common in urban black South Africans, but their IGF-I concentration is unknown. We aimed to compare serum IGF-I concentrations of African and Caucasian people, investigate their age-related IGF-I decline, and determine whether IGF-I could account, at least in part, for the high prevalence of noncommunicable diseases in black Africans. RESEARCH DESIGN AND METHODS: This cross-sectional study involved 211 African and 316 Caucasian men and women (aged 20-70 yr). Fasting glucose, insulin, lipids, albumin, creatinine, liver enzymes, cotinine, high-sensitivity C-reactive protein, reactive oxygen species, IGF-I, blood pressure (BP), and pulse wave velocity were determined. RESULTS:IGF-I was lower in Africans (P < 0.001) and in both ethnicities declined significantly by age quartiles (P < 0.001). In African men and women, IGF-I declined significantly from age quartile 1 to 2 (r = -0.65, P < 0.001), not seen in young Caucasian men and women (r = -0.08, P = 0.45; r = -0.10, P = 0.34). This was confirmed after adjustment for BP, insulin resistance, high-sensitivity C-reactive protein, cotinine, gamma-glutamyl transferase, and reactive oxygen species. Only young Africans showed significant negative correlations of IGF-I with BP, pulse wave velocity, and high-density lipoprotein cholesterol. CONCLUSIONS: Africans presented lower IGF-I levels than Caucasians due to an accelerated decline in serum IGF-I concentration prior to 40 yr of age. Strong associations of low serum IGF-I with blood pressure and arterial stiffness in young Africans suggest that the loss of cardiometabolic protection by IGF-I could predispose them to earlier disease onset.
Authors: Suchi Sood; Erik D Hanson; Matthew J Delmonico; Matthew C Kostek; Brian D Hand; Stephen M Roth; Ben F Hurley Journal: Eur J Appl Physiol Date: 2011-06-11 Impact factor: 3.078
Authors: Shani Botha-Le Roux; Olof Elvstam; Patrick De Boever; Nandu Goswami; Martin Magnusson; Peter M Nilsson; Hans Strijdom; Per Björkman; Carla M T Fourie Journal: J Clin Med Date: 2022-05-16 Impact factor: 4.964
Authors: Allen W Cowley; Chun Yang; Vikash Kumar; Jozef Lazar; Howard Jacob; Aron M Geurts; Pengyuan Liu; Alex Dayton; Theresa Kurth; Mingyu Liang Journal: Physiol Genomics Date: 2015-11-03 Impact factor: 3.107
Authors: Amani M Norling; Adam T Gerstenecker; Thomas W Buford; Bilal Khan; Suzanne Oparil; Ronald M Lazar Journal: Geroscience Date: 2019-12-05 Impact factor: 7.713
Authors: David G Dillon; Deepti Gurdasani; Johanna Riha; Kenneth Ekoru; Gershim Asiki; Billy N Mayanja; Naomi S Levitt; Nigel J Crowther; Moffat Nyirenda; Marina Njelekela; Kaushik Ramaiya; Ousman Nyan; Olanisun O Adewole; Kathryn Anastos; Livio Azzoni; W Henry Boom; Caterina Compostella; Joel A Dave; Halima Dawood; Christian Erikstrup; Carla M Fourie; Henrik Friis; Annamarie Kruger; John A Idoko; Chris T Longenecker; Suzanne Mbondi; Japheth E Mukaya; Eugene Mutimura; Chiratidzo E Ndhlovu; George Praygod; Eric W Pefura Yone; Mar Pujades-Rodriguez; Nyagosya Range; Mahmoud U Sani; Aletta E Schutte; Karen Sliwa; Phyllis C Tien; Este H Vorster; Corinna Walsh; Rutendo Zinyama; Fredirick Mashili; Eugene Sobngwi; Clement Adebamowo; Anatoli Kamali; Janet Seeley; Elizabeth H Young; Liam Smeeth; Ayesha A Motala; Pontiano Kaleebu; Manjinder S Sandhu Journal: Int J Epidemiol Date: 2013-12 Impact factor: 7.196